Recurrence Monitoring in NSCLC Using Circulating Tumor DNA
NCT03878537 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2021-03-23
Summary
This research study is investigating the role of cell free tumor DNA profiling in determining disease relapse and/or progression for patients with advanced NSCLC.
Conditions
- Non Small Cell Lung Cancer
Sponsors & Collaborators
-
Scripps Health
collaborator OTHER -
Lexent Bio, Inc.
collaborator INDUSTRY -
Scripps Translational Science Institute
lead OTHER
Principal Investigators
-
Marin Xavier · Scripps Health
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-14
- Primary Completion
- 2021-03-01
- Completion
- 2021-12-31
Countries
- United States
Study Locations
More Related Trials
-
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
NCT02245100 ·Status: COMPLETED
-
HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598
NCT00896909 ·Status: COMPLETED
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
NCT00213798 ·Status: COMPLETED ·Phase: NA
-
Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
NCT00899405 ·Status: RECRUITING
-
Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment
NCT02297087 ·Status: TERMINATED ·Phase: NA
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
NCT00898313 ·Status: RECRUITING
-
Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck
NCT00002695 ·Status: COMPLETED
-
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
NCT06482073 ·Status: RECRUITING
-
Molecular Profiling Protocol (SCRI-CA-001)
NCT00530192 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
NCT00685750 ·Status: TERMINATED ·Phase: NA
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
NCT00897117 ·Status: RECRUITING
-
Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma
NCT06863870 ·Status: ACTIVE_NOT_RECRUITING
-
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
NCT02178163 ·Status: RECRUITING ·Phase: NA
-
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
NCT02612350 ·Status: COMPLETED
-
Expressiona and Diagnostic Potential of miRNAs in NSCLC
NCT05815407 ·Status: COMPLETED
-
Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes
NCT02355587 ·Status: TERMINATED
-
Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer
NCT00898742 ·Status: TERMINATED
-
Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
NCT00568906 ·Status: TERMINATED
-
Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting
NCT05079113 ·Status: COMPLETED
-
Genetic Investigation of Solid Tumors Cohort
NCT01005225 ·Status: COMPLETED
-
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
NCT04354064 ·Status: RECRUITING
-
Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer
NCT05710679 ·Status: RECRUITING ·Phase: NA
-
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics
NCT03027401 ·Status: WITHDRAWN